囊性纤维化患者对慢性鼻窦炎的看法:高效调节剂治疗时代的症状优先级
该前瞻性观察研究纳入2019至2023年八中心69例成人囊性纤维化合并慢性鼻窦炎患者,通过SNOT-22及改良版SNOT-22评估症状重要性。鼻塞和鼻后滴漏为最高优先级;选择手术者较继续药物治疗者更重视睡眠和心理功能障碍症状;使用ETI与否的总症状重要性评分无显著差异,非ETI使用者有优先关注睡眠症状的趋势。
要点
- 鼻塞(69.6%)和鼻后滴漏(46.4%)是囊性纤维化合并慢性鼻窦炎患者最重视的症状。
- 选择手术者较继续药物治疗者更重视睡眠和心理功能障碍症状。
- 使用ETI与非ETI使用者的SNOT-22总症状重要性评分无显著差异。
核心结论
- 鼻塞和鼻后滴漏是囊性纤维化合并慢性鼻窦炎患者报告的最高优先级症状。
- 选择手术的患者优先关注睡眠和心理症状,突显其在术前讨论中的重要性。
- 非ETI使用者对睡眠改善的优先关注可能反映其独特的疾病影响和治疗需求,但需进一步研究。
研究设计与样本
- 前瞻性观察研究,2019至2023年于八个中心纳入69例成人囊性纤维化合并慢性鼻窦炎患者。
- 参与者完成22项鼻窦鼻 Outcome Test(SNOT-22)及改良SNOT-22症状重要性问卷。
- 按是否选择内镜鼻窦手术与继续药物治疗、以及是否使用elexacaftor/tezacaftor/ivacaftor(ETI)分组比较症状重要性。
主要发现
- 鼻塞重要者48例(69.6%),鼻后滴漏32例(46.4%),面部疼痛29例(43.3%),醒来疲倦27例(39.1%),疲劳26例(37.7%)。
- 选择手术组(n=23)较继续药物治疗组(n=49)更重视睡眠症状,睡眠中位评分19.0(四分位距12.0,25.0)vs 4.5(0.0,12.8),p<0.0001。
- 选择手术组(n=23)较继续药物治疗组(n=49)更重视心理功能障碍症状,中位评分17.0(7.0,26.0)vs 7.0(0.0,15.8),p=0.002。
- ETI使用者与非ETI使用者的SNOT-22总症状重要性评分相当(p=0.14)。
- 非ETI使用者(n=34)较ETI使用者(n=35)有优先关注睡眠症状的趋势,中位评分13.0(2.8,22.3)vs 6.0(2.0,17.0),p=0.055。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic rhinosinusitis (CRS) is common in people with cystic fibrosis (PwCF). Rhinologic symptom prioritization and areas that influence CRS treatment choices, including pursuing endoscopic sinus surgery (ESS), remain understudied. METHODS: Adult PwCF + CRS were enrolled at eight centers into a prospective, observational study (2019-2023). Participants were administered the 22-SinoNasal Outcome Test (SNOT-22) survey and a modified SNOT-22 instrument examining symptom importance. We determined importance rankings for individual symptoms and SNOT-22 symptom importance subdomains in two sets of subgroups-those pursuing ESS versus continuing medical management (CMT), and those on elexacaftor/tezacaftor/ivacaftor (ETI) versus not on ETI. RESULTS: Among 69 participants, the highest priorities were nasal congestion (n = 48, 69.6% important), post-nasal discharge (32, 46.4%), facial pain (29, 43.3%), waking up tired (27, 39.1%), and fatigue (26, 37.7%). Those electing surgery (n = 23) prioritized sleep and psychological dysfunction symptoms compared to those pursuing CMT (n = 49) (sleep median score = 19.0 [interquartile range: 12.0, 25.0] vs. 4.5 [0.0, 12.8]; p < 0.0001; psychological = 17.0 [7.0, 26.0] vs. 7.0 [0.0, 15.8]; p = 0.002). ETI users had comparable SNOT-22 total symptom importance scores to non-ETI users (p = 0.14). Non-ETI users (n = 34) showed a trend toward prioritizing sleep symptoms compared to ETI users (n = 35) (13.0 [2.8, 22.3] vs. 6.0 [2.0, 17.0]; p = 0.055). CONCLUSIONS: Nasal congestion and post-nasal discharge were top priorities reported by PwCF + CRS. Those electing surgery prioritized sleep and psychological symptoms, highlighting their importance in pre-operative discussions. Non-ETI users' prioritization of sleep improvement may highlight their unique disease impact and therapeutic needs; however, additional investigation is required.
引用
- Liu CM, Han EJ, Fischer JL, et al. Patient perspectives on chronic rhinosinusitis in cystic fibrosis: Symptom prioritization in the era of highly effective modulator therapy. Int Forum Allergy Rhinol. 2024. PMID: 38343143. doi:10.1002/alr.23332
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。